Concepedia

Steven Magnuson

SM

Statistics

Publications

45

Citations

3.6K

H-Index

30

Active since

1995

Affiliations

Constellation Pharmaceuticals (United States)(Current)

WuXi AppTec (China)

Gene Therapy Laboratory

Paraza Pharma (Canada)

University of Alberta

Steven Magnuson is an author at Constellation Pharmaceuticals (United States) specializing in pharmacology, medicinal chemistry, and drug discovery.

ORCID

Publications per year

1995–2024

45

Publications

45

Enhancer Activity Requires CBP/P300 Bromodomain-Dependent Histone H3K27 Acetylation

Ryan Raisner, Samir Kharbanda, Lingyan Jin et al. · Cell Reports · 2018 · 415 citations · Full text

, , +17

A Novel Tankyrase Small-Molecule Inhibitor Suppresses <i>APC</i> Mutation–Driven Colorectal Tumor Growth

Ted Lau, Emily Chan, Marinella Callow et al. · Cancer Research · 2013 · 320 citations

, , +17

Two-directional synthesis and its use in natural product synthesis

Steven Magnuson · Tetrahedron · 1995 · 209 citations

, , +10

Disrupting Acetyl-Lysine Recognition: Progress in the Development of Bromodomain Inhibitors

F. Anthony Romero, Alexander M. Taylor, Terry D. Crawford et al. · Journal of Medicinal Chemistry · 2015 · 189 citations · Full text

, , +8

Therapeutic Targeting of the CBP/p300 Bromodomain Blocks the Growth of Castration-Resistant Prostate Cancer

Lingyan Jin, Jesse Garcia, Emily Chan et al. · Cancer Research · 2017 · 152 citations · Full text

, , +17

1–5 of 45